Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
Dopamine Hydrochloride 40mg/ml Concentrate for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion. Clear, colourless or pale yellow solution. |
Each ml contains 40 mg dopamine hydrochloride.
Each 5 ml ampoule contains 200mg Dopamine hydrochloride
Excipient(s) with known effect:
Each 5mL ampoule contains 50 mg sodium metabisulfite.
Each 5mL ampoule contains less than 1 mmol sodium (23 mg) that is to say essentially “sodium-free”.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dopamine |
Dopamine exerts positive inotropic and chronotropic effects on the myocardium, acting as an agonist at beta-adrenergic receptors. Depending on the vascular bed being studied and the dose administered, dopamine can cause relaxation or contraction of vascular smooth muscle. |
| List of Excipients |
|---|
|
Sodium metabisulfite |
5 ml clear glass one point-cut (OPC) ampoules, glass Type I Ph Eur. borosilicate glass ampoules packed in cardboard cartons to contain 10 × 5ml ampoules.
Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
PL 02848/0130
14 September 1989 / 19 March 2008
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
